Sarepta Therapeutics (SRPT) Defended at Cantor Fitzgerald
Tweet
Share
E-mail
Get Alerts SRPT Hot Sheet
Price: $19.73 +9.49%
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 16
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 16
Join SI Premium – FREE
Cantor Fitzgerald analyst Alethia Young is reiterating their conviction on Sarepta Therapeutics (NASDAQ: SRPT) amid today's weakness.
The firm reiterated an Overweight rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FOMC minutes from July 28-29th meeting
- Kingsoft Cloud (KC) PT Raised to $21.40 at BofA Securities
- Lyntris opens at $15.50, below IPO price of $17.50
Create E-mail Alert Related Categories
Analyst Comments, Trader TalkRelated Entities
Cantor Fitzgerald, Alethia YoungSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
